Merck & Co. Faces Securities Fraud Class Action Lawsuit: Recover Losses with Levi & Korsinsky.
Merck & Co., Inc. (NYSE: MRK) is currently facing a securities fraud class action lawsuit that could impact shareholders who suffered losses between February 3, 2022, and February 3, 2025. If you are a shareholder and want to learn more about your legal rights, Levi & Korsinsky invites you to reach out before April 14, 2025, to explore your options.
The class action lawsuit against Merck centers around alleged misstatements made by the company regarding its anticipated Gardasil vaccine sales. According to the complaint, Merck assured investors that its Gardasil vaccine would generate $11 billion in sales by 2030. These optimistic projections were based on assumptions that Merck would successfully engage consumers and increase demand for Gardasil, particularly in China.
On February 4, 2025, Merck revealed it would not meet the $11 billion sales target for Gardasil. The company announced it would halt shipments to China "through at least midyear" to reduce channel inventories, citing weaker-than-expected demand in the region.
Merck's stock price dropped significantly following this announcement. The company’s stock fell from $99.79 per share on February 3, 2025, to $90.74 per share on February 4, 2025, a decline of more than 9% in just one day. This drop highlighted the financial impact of Merck's failure to meet its sales projections and the resulting loss of investor confidence.
If you are an investor in Merck & Co. and suffered financial losses as a result of these events, you may be eligible to join the class action lawsuit to recover your losses. Levi & Korsinsky, LLP, a trusted law firm specializing in shareholder rights litigation, is offering assistance in this matter. For more details and to submit a claim, click the link below:
Merck Securities Fraud Class Action Submission Form
If you wish to discuss your options or have questions, reach out to Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to connect with their experienced legal team.
The deadline to participate in this class action lawsuit is approaching. Shareholders must act before April 14, 2025, to ensure their eligibility for potential recovery. Don't miss this opportunity to take action and protect your rights as an investor.
Levi & Korsinsky LLP is a recognized leader in securities litigation, with a track record of recovering hundreds of millions of dollars for shareholders over the past two decades. With a dedicated team of over 70 professionals, the firm specializes in complex securities cases and has been featured in ISS Securities Class Action Services' Top 50 Report for seven consecutive years.
Kirby McInerney LLP Files BioAge Securities Class Action
